Joe Wiley

26 results

Swixx BioPharma is one of the largest agents for ethical pharmaceuticals serving research-based biopharma across central and eastern Europe. Photograph: Kiyoshi Ota/Bloomberg

Dublin pharma company Amryt said on Monday it has appointed Swiss pharma agent Swixx BioPharma to distribute its cholesterol drug Lojuxta across centr(...)

Blistering caused by epidermolysis bullosa (EB). Irish company Amryt  has developing a drug for the rare medical condition. Photograph: Dave Meehan

Shares in an Irish company developing a drug for a rare medical condition known as “butterfly skin” jumped over 50 per cent on Wednesday morning on th(...)

Mackin Group founder Andrew Mackin: “Spend time on personal development that will instil good habits.”

The first four of eight nominees in the International category of the EY Entrepreneur of the Year competition are profiled this week. The awards are r(...)

Amryt Pharma, which focuses on developing treatments to help patients with rare and orphan diseases, expects its listing on New York’s Nasdaq to complete in July. Photograph: iStock

Amryt Pharma, the Dublin-based biopharmaceutical company, almost doubled the total remuneration of its boss last year to $1.6 million (€1.42 million) (...)

The company said phase three efficacy and safety trial results for a new treatment for rare skin condition epidermolysis bullosa would be published later in the year and would represent a significant milestone for Amryt

Dublin-based biopharmaceutical company Amryt Pharma said revenue rose 30 per cent to $44.6 million (€41 million) in the first quarter of 2020. The co(...)

Amryt Pharma said the company has more contingency plans in place to deal with the crisis should they be required.

Dublin-based biopharmaceutical company Amryt Pharma recorded a 13.1 per cent increase in revenue last year, the company said in a trading update on Mo(...)

Amryt Pharma focuses on developing treatments to help patients with rare and orphan diseases. Photograph: iStock

Amryt Pharma, a Dublin-based biopharmaceutical company, said integration of Aegerion Pharmaceuticals, a company it acquired in September, is “progress(...)

‘Amryt is now very well-positioned to execute on our strategy of becoming a global leader in the rare and orphan disease space.’ Photograph: iStock

Amryt Pharma, the Dublin-based biopharmaceutical company, grew sales almost 20 per cent in the first nine months of its financial year, helped by sign(...)

Photograph: iStock

Amryt, an Irish pharmaceutical company focused on rare diseases, has agreed to acquire Aegerion Pharmaceuticals, a subsidiary of Canada-headquartered (...)

Reimbursement decisions in France and the UK led to revenue growth for one drug of 28.1 per cent in the first quarter of 2019 compared with a year earlier. Photograph: iStock

Irish pharmaceutical company Amryt said its revenues rose 13.3 per cent in 2018 to €14.5 million and the strong momentum continued into the first quar(...)

  • 1
  • 2
  • 3
  • Next
  • Last »